Benchmarking of the World Class of Haisco Pharmaceutical Group Company Ltd

Company: Haisco Pharmaceutical Group Company Limited

Bloomberg Ticker: 002653 SZ

Market capitalization: US $ 7,253m

Background: Haisco Pharmaceutical Group Company Limited focuses on researching, developing and producing new medicines, in particular in therapeutic areas such as anesthesia, parenteral food and liver disease. Mainly active in China, the hospitals and pharmacies, with a strong presence on the Chinese market and a growing focus on global innovation.

• The profitable growth rank of 5 had risen compared to the 7th rank of the previous period
• These are average performance compared to 360 medium health care companies worldwide
• The profit rank of 5 was better than the growth rank of 7
• The profit rank of 5 was higher compared to the 6th rank of the previous period
• These are average performance compared to peers
• The growth of 7 had risen compared to the 8th rank of the previous period
• This is below the average performance compared to colleagues

Safeguard: This content is only for information purposes. It is not intended as investment advice. Readers are not allowed to regard statements by the author (s) as formal recommendations and must consult their financial adviser before they make investment decisions. Although the information provided is considered accurate, this can include errors or inaccuracies. The author (s) cannot be held liable for all actions taken as a result of reading this article.